Visa Forecast, price target & analysts
Visa Target price 2025 - Analyst rating & recommendation
Visa Classifications & Recommendation:
Visa Price Target
| Target Price | $408.00 |
| Price | $338.92 |
| Potential | 20.38% |
| Number of Estimates | 40 |
| 40 Analysts have issued a price target Visa 2026 . The average Visa target price is $408.00. This is 20.38% higher than the current stock price. The highest price target is $472.50 39.41% , the lowest is $307.25 9.34% . | |
| A rating was issued by 47 analysts: 39 Analysts recommend Visa to buy, 8 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Visa stock has an average upside potential 2026 of 20.38% . Most analysts recommend the Visa stock at Purchase. |
Sales and Margin forecast 2026, 2027 & 2028
42 Analysts have issued a sales forecast Visa 2026 . The average Visa sales estimate is $45.3b . This is 13.34% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $47.3b 18.24% , the lowest is $43.2b 8.06% .
This results in the following potential growth metrics:
Revenue Estimates
| 2025 | $40.0b | 11.34% |
|---|---|---|
| 2026 | $45.3b | 13.34% |
| 2027 | $49.9b | 10.12% |
| 2028 | $54.5b | 9.25% |
29 Analysts have issued an Visa EBITDA forecast 2026. The average Visa EBITDA estimate is $31.8b . This is 14.56% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $34.0b 22.31% , the lowest is $29.6b 6.55% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2025 | $27.8b | 10.70% |
|---|---|---|
| 2026 | $31.8b | 14.56% |
| 2027 | $35.1b | 10.44% |
| 2028 | $39.9b | 13.48% |
| 2029 | $42.5b | 6.63% |
EBITDA Margin
| 2025 | 69.44% | 0.57% |
|---|---|---|
| 2026 | 70.19% | 1.08% |
| 2027 | 70.39% | 0.28% |
| 2028 | 73.12% | 3.88% |
43 Visa Analysts have issued a net profit forecast 2026. The average Visa net profit estimate is $25.0b . This is 24.87% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $26.1b 30.36% , the lowest is $23.8b 18.85% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2025 | $20.1b | 3.09% |
|---|---|---|
| 2026 | $25.0b | 24.87% |
| 2027 | $28.3b | 12.80% |
| 2028 | $31.8b | 12.37% |
| 2029 | $36.7b | 15.59% |
Net Margin
| 2025 | 50.15% | 7.41% |
|---|---|---|
| 2026 | 55.25% | 10.18% |
| 2027 | 56.60% | 2.44% |
| 2028 | 58.22% | 2.86% |
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2029
43 Analysts have issued a Visa forecast for earnings per share. The average Visa EPS is $13.05 . This is 26.58% higher than earnings per share in the financial year 2025. The highest EPS forecast is $13.62 32.10% , the lowest is $12.42 20.47% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2025 | $10.20 | 6.47% |
|---|---|---|
| 2026 | $13.05 | 27.94% |
| 2027 | $14.72 | 12.80% |
| 2028 | $16.54 | 12.36% |
| 2029 | $19.11 | 15.54% |
P/E ratio
| Current | 32.87 | 3.68% |
|---|---|---|
| 2026 | 25.98 | 20.97% |
| 2027 | 23.03 | 11.35% |
| 2028 | 20.49 | 11.03% |
| 2029 | 17.73 | 13.47% |
Based on analysts' sales estimates for 2026, the Visa stock is valued at an EV/Sales of 14.37 and an P/S ratio of 14.23 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 16.28 | 3.95% |
|---|---|---|
| 2026 | 14.37 | 11.75% |
| 2027 | 13.05 | 9.19% |
| 2028 | 11.94 | 8.46% |
P/S ratio
| Current | 16.13 | 3.97% |
|---|---|---|
| 2026 | 14.23 | 11.77% |
| 2027 | 12.92 | 9.19% |
| 2028 | 11.83 | 8.46% |
Current Visa Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Buy
➜
Buy
|
Unchanged | Oct 29 2025 |
| Macquarie |
Outperform
➜
Outperform
|
Unchanged | Oct 29 2025 |
| Raymond James |
Outperform
➜
Outperform
|
Unchanged | Oct 29 2025 |
| Wells Fargo |
➜
Overweight
|
Initiated | Oct 22 2025 |
| Citigroup |
➜
Buy
|
Initiated | Oct 22 2025 |
| Baird |
Outperform
➜
Outperform
|
Unchanged | Oct 06 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Jul 31 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
UBS:
Buy
➜
Buy
|
Oct 29 2025 |
|
Unchanged
Macquarie:
Outperform
➜
Outperform
|
Oct 29 2025 |
|
Unchanged
Raymond James:
Outperform
➜
Outperform
|
Oct 29 2025 |
|
Initiated
Wells Fargo:
➜
Overweight
|
Oct 22 2025 |
|
Initiated
Citigroup:
➜
Buy
|
Oct 22 2025 |
|
Unchanged
Baird:
Outperform
➜
Outperform
|
Oct 06 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Jul 31 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
